Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05135845
Title Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma (METIMGAST)
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.